Immunomodulators and Immunostimulants Flashcards
IL-2, Aldeslukin
- MOA: stimulates production and activity of T cells, increases number of B cells and stimulates macrophages, increases NK cell activity, induces IFN gamma production.
- Kinetics: IV admin
- SE: Must be admin in hospital due to serious toxicity. Look at the sheet cause theres a ton of shit, pretty much anything you can think of is an SE.
- CI: known hypersensitivity to IL-2
- Use: metastic renal cell carcinoma, malignant melanoma
Oprelvekin, rh-IL-11
- MOA: recombinant IL-11
- Kinetics: SubQ admin
- SE: fluid retention, peripheral edema, moderate decreases in hemoglobin are possible
- Use: prevent severe chemo-induced thrombocytopenia and reduce platelet transfusion need post-myelosuppressive chemo.
Granulocyte Colony-Stimulating Factor; Filgrastim
- MOA: human recombinant G-CSF
- Kinetics: SubQ (pegylated to provide slow-release depot) or slow IV infusion.
- SE: most common is bone pain, local skin irritation at injection site.
- USe: severe neutropenia post autologous hematopoeitc stem cell transplant, neutropenia due to cancer chemo or interferon therapy, reduce neutropenia due to Zidovudaine
Epoetin alfa, Darbopoetin alfa
- MOA: recombinant human EPO, acts on EPO receptors on red cell progenitors to stimulate erythroid production,.
- Use: anemia due to chemo when Hgb
Interferon alfa-2a/2b
Used to tx chronic Hep C with reibavirin and protease inhibitors. Approved to tx hairy cell leukemia, karposi sarcoma, codylomata acuminata (injected into wart)
Interferon Alfa-n3
Used to Tx condylomata acuminata and tx hep C in pts refractory to IFN-2a/2b
Interferon beta 1-b
Suppresses class II MHC presentation and decreases antigen presentation in nervous system, decreases occurrence of exacerbation of relapsing-remitting MS, IFN-B-1a is also approved for tx of MS.
Interferon gamma-1b
Potent phagocyte-activating effects: enhances killing of bacterial and protozoan pathogens; enhances superoxide production in macrophages, activates neutrophils, NK cells, potentiates effects of TNFa.
Increases T cell proliferation in response to Th1; increases MHC I and II. More potent than alfa and beta interferons. Used to reduce infection severity associated with chronic granulomatous disease.
2. SubQ
SE of IFN treatment
- CI in pts w/history of hypersensitivity to albumin or IFN
- Depression is common (pretreat with antidepressents)-most deaths are due to suicide with these
- confustion/fatigue
- flu-like symptoms
- Injection site rxns
- Bone marrow suppression
- Alopecia.
- Increase in serum TGs>400 may predispose to pancreatitis
- Increase in ALT greater than 2-5x baseline may require discontinuation.